Ullswater Investments · EU Funding Calls
All calls › Horizon Europe › HORIZON-MISS-2027-02-CANCER-01
ForthcomingHorizon Europe

Leveraging functional genomics to reveal novel targets for cancer treatment

Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes: Researchers and health professionals gain a deeper understanding of the functional effects of tumour heterogeneity during cancer initiation and progression, supporting the identification of more precise and novel therapeutic targets. Researchers, health…

Deadline 16 Sep 2027Opens 10 Feb 2027Budget €32.3MIndicative grants 4EU contribution per project €7M–€8MSingle stageHORIZON Research and Innovation Actions

Funding and competition

  • 4grants expected (official)
  • €7M–€8MEU contribution per project
  • €7.8Mmedian EU grant of the most similar funded projects
  • 67projects funded in earlier topics of this programme line

Success rates vary widely between topics (often from below 5% to above 30%). Ask us for the success-rate history of this topic before you commit to a proposal.

Organisations with a track record in this topic

Organisations that took part in the EU-funded projects most similar to this call (Horizon Europe and Horizon 2020), ranked by how close those projects are to the call, how recent they are and whether the organisation coordinated them. Being listed does not mean an organisation is looking for partners: use the list to target your outreach.

OrganisationCountryTypeSimilar EU projectsAs coordinatorExamples (CORDIS)
Deutsches Krebsforschungszentrum Heidelberg
Heidelberg
GermanyResearch organisation91THRIVE, 4.UNCAN.eu, EOSC4Cancer
Katholieke Universiteit Leuven
Leuven
BelgiumUniversity102GLIOMATCH, EASI-OMICS, B-specific
Erasmus Universitair Medisch Centrum Rotterdam
Rotterdam
NetherlandsUniversity120NEUcrest, EuCanImage, EOSC4Cancer
Institut National De La Sante Et De La Recherche Medicale
Paris
FranceResearch organisation1124.UNCAN.eu, ONCOBIOME, LIMA
Biobanks And Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric)
Graz
AustriaResearch organisation71THEODORA, EuCanImage, CANDLE
Institut Curie
Paris
FranceResearch organisation84THEODORA, NEUcrest, UM Cure 2020
Medizinische Universitaet Wien
Wien
AustriaUniversity61PhotoMel, 4.UNCAN.eu, NEUcrest
Centre National De La Recherche Scientifique Cnrs
Paris
FranceResearch organisation80CANDLE, EOSC4Cancer, HIT-GLIO
Universiteit Utrecht
Utrecht
NetherlandsUniversity60SPACETIME, CANDLE, CUE-CAN
Stichting Amsterdam Umc
Amsterdam
NetherlandsResearch organisation72SPACETIME, RHAPSODY, CardioReGenix
European Molecular Biology Laboratory
Heidelberg
GermanyResearch organisation60PhotoMel, CANDLE, EOSC4Cancer
Oslo Universitetssykehus Hf
Oslo
NorwayUniversity70CANDLE, GLIOMATCH, EU-CIP
Fondazione Irccs Istituto Nazionale Dei Tumori
Milan
ItalyResearch organisation63ONCOBIOME, LATE-AYA, IDEA4RC
Fundacio Privada Institut D'Investigacio Oncologica De Vall-Hebron (Vhio)
Barcelona
SpainResearch organisation604.UNCAN.eu, EOSC4Cancer, EU-CIP
Charite - Universitaetsmedizin Berlin
Berlin
GermanyUniversity61CANDLE, EU-CIP, ONCOBIOME

Spanish organisations with experience in this field

The Spanish organisations that appear most often in the closest funded projects.

What a typical winning consortium looks like

  • 15partners (median)
  • 8countries (median)
  • 12%of partners are SMEs
Research organisation 37%University 33%Company 17%Other 9%Public body 4%

Based on the 25 funded projects closest to this call. Use it as a benchmark, not a rule: always check the call conditions for the minimum consortium.

Most similar funded projects

Read their CORDIS pages to see the full consortium, results and deliverables.

  • THRIVE – Tumour-host interactions in liver cancer of childhood and adults (HORIZON · 2023 · HORIZON-MISS-2023-CANCER-01-01)
  • PhotoMel – Decoding Early-Life UVA and Skincare Additive Interactions Driving Melanoma Risk and Progression in Young Adults (HORIZON · 2026 · HORIZON-MISS-2025-02-CANCER-02)
  • 4.UNCAN.eu – A Coordination and Support Action to prepare UNCAN.eu platform (HORIZON · 2022 · HORIZON-MISS-2021-UNCAN-01-01)
  • SPACETIME – SPatial Analysis of Cancer Evolution in the Tumour Immune MicroEnvironment (HORIZON · 2024 · HORIZON-MISS-2023-CANCER-01-01)
  • THEODORA – immunoTHErapies targeting neOgenes in paeDiatric and adOlescent saRcomAs (HORIZON · 2026 · HORIZON-MISS-2025-02-CANCER-04)
  • NEUcrest – Training European Experts in Multiscale Studies of Neural Crest Development and Disorders: from Patient to Model Systems and Back again. (H2020 · 2019 · MSCA-ITN-2019)

Live partner requests

Organisations actively looking for partners publish their requests on these official platforms.

Partner search on this topic

On the official topic page, open “Partner search announcements” to see organisations that have declared interest in this exact topic, or publish your own (EU Login required).

Open the topic ↗

Health NCP Net

Network of Health National Contact Points: partner search, brokerage events and proposal support for Cluster 1 Health and IHI.

Open ↗

EU Funding & Tenders Partner Search

Search all organisations registered in the portal by keyword, programme, country and organisation type.

Search organisations ↗

Enterprise Europe Network

Europe's largest database of business, technology and R&D cooperation requests. Filter by “Research and development request”.

Browse requests ↗

Upcoming info days and brokerage events

Brokerage events are where most consortia are built.

All EU funding events →

Building a consortium for this call?

Publish what you are looking for or what you can offer on the Ullswater partner board. We review each request, publish it on this page and introduce you to suitable partners.

Post a partner request

Track-record data: CORDIS open data (European Commission), organisation level only, refreshed weekly. Rankings are calculated automatically by Ullswater Investments from text similarity between the call and funded projects; they are indicative.